Related Experiment Videos

Characterization of NMDA-coupled and dopamine reuptake carrier coupled [3H]-TCP binding sites in guinea pig brain

A A Reid¹, J A Monn, A E Jacobson

¹Laboratory of Medicinal Chemistry, NIDDK, NIH, Bethesda, MD 20892.

NIDA Research Monograph

|January 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The bacterial quorum sensing molecule, 2-heptyl-3-hydroxy-4-quinolone (PQS), inhibits signal transduction mechanisms in brain tissue and is behaviorally active in mice.

Pharmacological research·2021

Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects.

Pharmacology, biochemistry, and behavior·2017

Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.

The Journal of pharmacology and experimental therapeutics·2017

The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.

The Journal of pharmacology and experimental therapeutics·2016

Effects of LY354740, a novel glutamatergic metabotropic agonist, on nonhuman primate hypothalamic-pituitary-adrenal axis and noradrenergic function.

CNS spectrums·2004

Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

British journal of pharmacology·2002

See all related articles